Optical Communication Lead for MRI-Safe Active Implantable Devices

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Active implantable medical devices (AIMDs) are not safely usable during magnetic resonance imaging (MRI) sessions, especially with strong static magnetic fields, as they can be damaged or cause tissue injuries due to electromagnetic interactions, and current methods require switching them off, limiting the ability to optimize neurostimulation parameters effectively.

Innovation Solution

A kit-of-parts including an AIMD with an encapsulation unit made of non-metallic materials, an optical communication system using optical fibres for remote control and feedback, allowing safe operation and visualization of brain activity during MRI, enabling precise control and analysis of stimulation parameters.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If an AIMD is used during MRI sessions, then the ability to optimize neurostimulation parameters and visualize brain activity is improved, but the risk of device damage and tissue injury increases due to electromagnetic interactions

Engineering Contradiction:
Improveability to optimize neurostimulation parametersVSAvoidelectromagnetic interactions causing device damage and tissue injury
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces electrical communication and control systems with optical systems. Optical fibres transmit control signals and data between the external programming device and the implanted device, eliminating conductive electrical pathways that would otherwise be susceptible to MRI-induced electromagnetic interference and tissue heating.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces optical fibres as an intermediary medium for communication and power transfer. These fibres act as a bridge between external control systems and the implanted device, allowing signal transmission without direct electrical contact that would be vulnerable to MRI electromagnetic fields.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If the AIMD is switched off during MRI to avoid damage, then safety is improved, but the ability to control and monitor stimulation parameters is lost

Engineering Contradiction:
Improvesafety during MRIVSAvoidcontrol and monitoring of stimulation parameters
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The patent substitutes electrical communication pathways with optical pathways using fibres. This allows the device to remain operational during MRI scans because optical signals are not affected by the electromagnetic fields generated during MRI, enabling continuous control and monitoring without compromising safety.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Use of energy by moving object

If conductive wires are used for energy transfer, then electrical energy delivery is efficient, but RF-induced heating and tissue burns occur during MRI

Engineering Contradiction:
Improveelectrical energy delivery efficiencyVSAvoidRF-induced heating and tissue burns
Core Design Contradiction:
Use of energy by moving objectVSObject-generated harmful factors

Solution Approach 1:

The patent replaces electrical energy transfer through conductive wires with optical energy transfer through optical fibres. The fibres transmit optical energy that can be converted to electrical energy at the target site, avoiding the RF-induced heating problem that occurs with conductive wires during MRI while maintaining efficient energy delivery.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables safe and reliable operation of AIMDs during MRI, allowing for the optimization of neurostimulation parameters and improved understanding of treatment mechanisms by ensuring consistent pulse delivery and monitoring biomarkers without tissue damage.

Implementation Method 1

an optical communication lead (104) comprising an optical fibre (1040) for establishing an optical communication between the AIMD and the external communication unit (102)

Methodology Applied
Scientific EffectOptical fibre transmission: Optical Fibre

Implementation Method 2

an implanted communication photodetector (20Pi) facing a portion of wall having a given transmittance to wavelength selected within the range comprised between 380 nm and 5 μm

Methodology Applied
Scientific EffectPhotoelectric effect: Photoelectric Effect

Data Source

PatentUS11951305B2Active implantable stimulating device for use with an MRI-device
Publication Date: 2024.04.09 SYNERGIA MEDICAL
  • US11951305B2 patent drawing
  • US11951305B2 patent drawing
  • US11951305B2 patent drawing

AI summary

A kit-of-parts for visualizing by a magnetic resonance imaging (MRI) technique including a functional magnetic resonance imaging (fMRI) technique, regions of a central nervous system of a patient having an implanted active implantable medical device (AIMD) is provided. The kit-of-parts is provided and includes:the AIMD, which can be used exposed to the electromagnetic conditions for MR-images acquisition,an external processing unit for controlling the AIMD,an optical communication lead for establishing a two-way optical communication between the AIMD andan external communication unit which is controlled by the external processing unit.A patient having an implanted AIMD can be treated in a conventional MR-device for imaging, e.g., a brain region. The other elements of the kit-of-parts allow controlling the functions of the AIMD and following any effects of a stimulation on the brain region thus imaged.